The content on this site is intended for healthcare professionals only
Dr Henk Luiting speaks to ecancer at EMUC 2019 in Vienna about following up from MRI scans in low-grade prostate cancer patients.
He expands on the work of the PRIAS study which is a large exploration of low-grade prostate cancer risk men.
Dr Luiting explains some of the pros and cons of MRI scans, with emphasis on knowing when to target biopsy.
New classification for identifying HR myeloma based on cytogenetic abnormalities
Tele-mentoring: Impact of project ECHO
SABCS 2023: Latest breast cancer diagnostics guidelines
Genomic testing: Awareness and effective communication between healthcare professionals and patients
The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer
Choosing Wisely in radiology Tanzania
Why tumour markers are not recommended as screening tests
Digital rectal examination is not useful as a solitary screening tool for prostate cancer in young men
Single intensive screening intervention using PSA and Stockholm3 in combination might reduce prostate cancer mortality
